International Stroke Conference 2025  /  Updates on Cerebral White Matter Disease in 2025: Mechanisms, Implications, Treatment  /  Prevention and Treatment of White Matter Disease
Logo

American Heart Association

  8
  0

Final ID:

Prevention and Treatment of White Matter Disease

  • Gottesman, Rebecca  ( NINDS , Bethesda , Maryland , United States )
  • Rost, Natalia  ( MASSACHUSETTS GENERAL HOSPITAL , Winchester , United States Minor Outlying Islands )
  • Wardlaw, Joanna  ( University of Edinburgh , Edinburgh , United Kingdom )
    • Author Disclosures:
    Rebecca Gottesman: DO NOT have relevant financial relationships | Natalia Rost: DO NOT have relevant financial relationships | Joanna Wardlaw: DO NOT have relevant financial relationships
Meeting Info:

International Stroke Conference 2025

2025

Los Angeles, CA

Session Info:

Updates on Cerebral White Matter Disease in 2025: Mechanisms, Implications, Treatment

Friday, 02/07/2025 , 09:15AM - 10:45AM

ISC Invited Symposium

More abstracts on this topic:
Imaging Markers of White Matter Disease and Definitions

Wardlaw Joanna, Bath Philip

White Matter Disease and Cognitive Impairment

Gurol Edip

More abstracts from these authors:
Imaging Markers of White Matter Disease and Definitions

Wardlaw Joanna, Bath Philip

Cerebral small vessel disease and relationship to post-stroke cognitive outcomes- epidemiology, imaging, biomarkers, and potential therapeutic targets

Smith Eric, Bath Philip, Wardlaw Joanna

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.

   Rate this abstract  (Maximum characters: 500)